BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Holistic medicine
,
Clofibrate
,
rs2300478
,
FGF21
,
Angiogenesis
,
HIV infection
,
Prostate
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
gja1 protein, human
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
No genes found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Breast cancer MDA231-BrM2 brain metastatic cells with CX43 shRNA co-cultured with astrocytes
Myometrium gene expression in response to medroxyprogesterone acetate
Explore Curated Studies Results
Literature
Most Relevant Literature
Post translational modifications of connexin 43 in ventricular arrhythmias after myocardial infarcti…
Novel mutations in GJA1 in two Brazilian families with oculodentodigital dysplasia.
GJA1-20k Rescues Cx43 Localization and Arrhythmias in Arrhythmogenic Cardiomyopathy.
Connexin channels modulation in pathophysiology and treatment of immune and inflammatory disorders.
GJA1 reverses arsenic-induced EMT via modulating MAPK/ERK signaling pathway.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Foci of Tumor Heterogeneity in Diffuse Low-Grade Gliomas
Connexin Genotypes in Cystic Fibrosis
Genetic and Functional Analysis of Craniometaphyseal Dysplasia (CMD)
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ